Increased systemic exposure of once‐daily tacrolimus in renal transplant recipients on marine omega‐3 fatty acid supplementation-Reference-Cited by-同舟云学术

Increased systemic exposure of once‐daily tacrolimus in renal transplant recipients on marine omega‐3 fatty acid supplementation

Published:2021-06-08 Issue:7 Volume:34 Page:1322-1324
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Robertsen Ida¹^ORCID,Åsberg Anders¹²,Jenssen Trond G.²³⁴,Gence Berfin¹,Tore Vethe Nils⁵,Midtvedt Karsten²,Svensson My H. S.⁴⁶,Eide Ivar Anders⁶

Affiliation:

1. Section for Pharmacology and Pharmaceutical Biosciences Department of Pharmacy University of Oslo Oslo Norway

2. Department of Transplantation Medicine Oslo University Hospital Oslo Norway

3. Metabolic and Renal Research Group UiT The Artic University of Norway Tromsø Norway

4. Institute of Clinical Medicine University of Oslo Norway

5. Department of Pharmacology Oslo University Hospital Oslo Norway

6. Division of Medicine Department of Renal Medicine Akershus University Hospital Lørenskog Norway

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.13917

Reference10 articles.

1. Effects of marine n‐3 fatty acid supplementation in renal transplantation: A randomized controlled trial

2. The Association between Marine n-3 Polyunsaturated Fatty Acid Levels and Survival after Renal Transplantation

3. Omega-3 Polyunsaturated Fatty Acids Affect Sirolimus Exposure in Kidney Transplant Recipients on Calcineurin Inhibitor-Free Regimen

4. Effect of n‐3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo‐controlled study;Busnach G;J Nephrol,1998

5. Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: in vitro and in vivo studies in rats;Hirunpanich V;Int J Pharm,2008